title: Rituximab is an alternative in a case of contra-indication of cyclophosphamide in Wegener's granulomatosis.
authors.forename: Claude
authors.initials: C
authors.lastname: Bachmeyer
authors.forename: Jean-François
authors.initials: JF
authors.lastname: Cadranel
authors.forename: Renato
authors.initials: R
authors.lastname: Demontis
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D000075202:Contraindications; D003520:Cyclophosphamide; D014890:Granulomatosis with Polyangiitis / Q000188:drug therapy*; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D007166:Immunosuppressive Agents; D008875:Middle Aged; D012074:Remission Induction; D000069283:Rituximab
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D007166:Immunosuppressive Agents; D000069283:Rituximab; D003520:Cyclophosphamide